Medication info

Langaton Capsule 30 mg (Lansoprazole)

Prescription medicationHard capsuleOralExpired
Ingredient · strength
Lansoprazole›30mg / 1 capsule
Manufacturer / importer
Kwangdong Pharmaceutical Co., Ltd.
Appearance
A hard capsule filled with white granules that are white to light brown, with a green upper part and a white lower part.
Packaging
30 capsules [10 capsules/PTP (PVDC)x3]
Approval status
Expired

MFDS item code 201104067 · Approved 2011.06.30

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of ulcers and Helicobacter pylori eradication, treatment of reflux disease, and suppression of excessive gastric acid secretion
Who takes it
Adults · Children
Adult dose
This medicine should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure the entire dose is taken, rinse the glass with twice as much juice or more and drink immediately. Do not chew or crush the contents after opening this medicine. Short-term treatment of active duodenal ulcer: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to reduce recurrence of duodenal ulcer: Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if necessary. Eradication of Helicobacter pylori to reduce recurrence of duodenal ulcer: Administer lansoprazole 30 mg with amoxicillin 1,000 mg three times daily (every 8 hours) for 14 days. Maintenance treatment following treatment of duodenal ulcer: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of NSAID-induced gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction of the risk of NSAID-induced gastric ulcer: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease: Administer lansoprazole 15 mg orally once daily for 8 weeks Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance treatment following treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome: The lansoprazole dosage for pathological hypersecretory conditions varies for each patient. Treatment in adults is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of 90 mg twice daily have been administered. If the daily dose exceeds 120 mg, it should be given in divided doses. Since clearance of this medicine is reduced in older adults, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. Since metabolism and excretion of this medicine may be delayed in patients with hepatic impairment, administer with caution, including dose adjustment as appropriate.
Child dose
Children and adolescents aged 12 ∼ 17 years, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years, short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, over 30 kg: 30 mg once daily for 12 weeks

Ingredients

Manufacturer
Kwangdong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of ulcers and Helicobacter pylori eradication, treatment of reflux disease, and suppression of excessive gastric acid secretion

  • Active duodenal ulcer
  • active benign gastric ulcer
  • duodenal ulcer recurrence
  • NSAID-induced gastric ulcer
  • symptoms related to gastroesophageal reflux disease
  • erosive esophagitis
  • Zollinger-Ellison syndrome
  • pathological hypersecretion conditions.
View approved original text

This medication is used for the short-term treatment of active duodenal ulcers and active benign gastric ulcers. It also aids in eradicating Helicobacter pylori to prevent recurrence of duodenal ulcers. It is utilized for maintenance therapy of duodenal ulcers post-treatment and is effective in treating gastric ulcers induced by non-steroidal anti-inflammatory drugs (NSAIDs) and reducing the risk of occurrence. It can also be used for the short-term treatment of gastroesophageal reflux disease and erosive esophagitis as well as for pathological hypersecretion conditions such as Zollinger-Ellison syndrome.

How to take

Adult dose

This medicine should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure the entire dose is taken, rinse the glass with twice as much juice or more and drink immediately. Do not chew or crush the contents after opening this medicine. Short-term treatment of active duodenal ulcer: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to reduce recurrence of duodenal ulcer: Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if necessary. Eradication of Helicobacter pylori to reduce recurrence of duodenal ulcer: Administer lansoprazole 30 mg with amoxicillin 1,000 mg three times daily (every 8 hours) for 14 days. Maintenance treatment following treatment of duodenal ulcer: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of NSAID-induced gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction of the risk of NSAID-induced gastric ulcer: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease: Administer lansoprazole 15 mg orally once daily for 8 weeks Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance treatment following treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome: The lansoprazole dosage for pathological hypersecretory conditions varies for each patient. Treatment in adults is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of 90 mg twice daily have been administered. If the daily dose exceeds 120 mg, it should be given in divided doses. Since clearance of this medicine is reduced in older adults, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. Since metabolism and excretion of this medicine may be delayed in patients with hepatic impairment, administer with caution, including dose adjustment as appropriate.

Child dose

Children and adolescents aged 12 ∼ 17 years, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years, short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, over 30 kg: 30 mg once daily for 12 weeks

Precautions

This medication should not be used in patients who are allergic to any of its components or to benzimidazole derivatives. It is also advisable not to administer it to individuals with hypersensitivity to penicillin or macrolide antibiotics. Pregnant patients or those with genetic issues such as lactose intolerance are recommended to avoid this medicine. Care should be taken when administering to patients with a history of drug allergies, poor liver function, elderly individuals, nursing mothers, and children. While rare, serious side effects including anaphylaxis, blood disorders, liver dysfunction, and severe skin reactions may occur during use; if any such symptoms appear, the medication should be discontinued immediately, and medical attention should be sought. As this drug suppresses gastric acid secretion, it may interact with other medications. Caution is especially needed when co-administering with HIV therapies or certain antibiotics and anticoagulants, and adjustment or monitoring of drug intervals may be required. Prolonged use may lead to vitamin B12 deficiency or hypomagnesemia; regular check-ups are recommended. Additionally, the risk of fractures may increase, thus caution is necessary with long-term use. Dizziness, drowsiness, or vision disturbances may occur during use; exercise caution when driving or operating machinery. Pregnant or nursing women should refrain from using this drug, and if it is essential, professional consultation is necessary. In cases of overdose, immediate emergency treatment and symptomatic care are required as it cannot be eliminated by hemodialysis.

Side effects

Anaphylaxis, generalized rash, facial swelling, dyspnea, shock, pancytopenia, agranulocytosis, hemolytic anemia, neutropenia, thrombocytopenia, anemia, jaundice, elevated AST, elevated ALT, toxic hepatic dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, interstitial nephritis, acute renal failure, membranous colitis, headache, diarrhea, abdominal enlargement, allergic reactions, back pain, weakness, candidiasis, malignancy, chills, chest pain, edema, fever, flu-like symptoms, halitosis, infection, lethargy, neck stiffness, pelvic pain, angina, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory tract infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorder, respiratory disorder, rhinitis, sinusitis, wheezing, acne, hair loss, pruritus, rash, urticaria, contact dermatitis, dry skin, nail disease, skin cancer, skin disease, sweating, abnormal vision, amblyopia, blepharitis, cataract, conjunctivitis, dry eyes, ear disease, eye disease, glaucoma, abnormal olfaction, photophobia, retinal degeneration, taste disorder, blurred vision, deafness, ocular pain, otitis media, taste alteration, tinnitus, visual field narrowing, urinary disorders, renal pain, penile disease, testicular disease, urethral pain, polyuria, frequency of urination, urinary retention, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, nephrolithiasis, hepatotoxicity, vomiting, pancreatitis, abdominal pain, taste alteration, aplastic anemia, leukopenia, thrombotic thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile-associated diarrhea, fracture, myositis, erythema multiforme, acute generalized exanthematous pustulosis, speech disorders, urinary retention, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated γ-GTP, weakness, hyponatremia, increased total cholesterol, decreased total cholesterol, tongue paralysis, lip paralysis, limb paralysis, constipation, abdominal pain, dizziness, drowsiness, insomnia, paralysis, depressive state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture, and it is safe to keep it at a temperature between 1°C and 30°C. Storing it this way helps maintain the medication's effectiveness and prevents deterioration.

Appearance and packaging

Appearance

A hard capsule filled with white granules that are white to light brown, with a green upper part and a white lower part.

Package unit

30 capsules [10 capsules/PTP (PVDC)x3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.